Craft Cannabis is the Future & Micro-Cultivators Will Lead the Way
December 3, 2021
Ryan Allway December 3rd, 2021 App, Exclusive, News, Top Story Canada’s legal cannabis industry is flooded with products that prioritize profits over quality. While many consumers are price-sensitive, Deloitte Canada found that 86% of Millennial and Gen Z consumers are willing to buy premium products. These trends mirror many... Read more
Ryan Allway November 11th, 2021 News, Top Story The legal cannabis industry has grown from humble beginnings in the early 2000s into a multi-billion dollar global industry. In addition to THC-containing products capturing market share from the black market, CBD and other cannabinoids have exploded onto the health and... Read more
Silo Pharma’s Sponsored Research Agreement with Columbia Could Yield a New Alzheimer’s Disease Treatment
November 3, 2021
Ryan Allway November 3rd, 2021 Psychedelics, Top Story Alzheimer’s disease is the sixth leading cause of death in the U.S. and a leading cause of disability and poor health. By 2050, iHealthcareAnalyst projects the number of people suffering from AD will reach 14 million in the U.S. alone. Yet,... Read more
How to Solve the Trucking Industry’s Cannabis Problem
October 22, 2021
Ryan Allway October 22nd, 2021 News, Top Story The federal government heavily regulates the trucking industry. For instance, drivers have to log how many hours they’ve rested each day to ensure they meet mandatory minimums. Therefore, it’s not surprising that the Department of Transportation prohibits drivers from using any... Read more
Ryan Allway October 21st, 2021 News, Top Story The global cannabis industry is projected to reach nearly $20 billion in value this year and grow at a 27% compound annual growth rate through 2030, according to Quince Market Insights. But rather than focusing on industry giants, investors may want... Read more
Ryan Allway October 15th, 2021 App, Exclusive, News, Top Story Cannabis-based pharmaceutical drug products remain a niche market despite the plant’s significant promise. By acting on the endocannabinoid system, a widespread neuromodulator that plays an important role in everything from central nervous system development to synaptic plasticity, cannabinoids have... Read more
RYAH’s IoT Devices Can Deliver Psychedelic Medicines, Advance the Industry
September 30, 2021
Ryan Allway September 30th, 2021 News, Top Story In the emerging world of psychedelic medicine, there is an urgent need to document, quantify, and qualify the efficacy of treatments. The process is underway. This summer there were at least 56 clinical trials recruiting participants, with more already started and... Read more
Ketamine Offers Promise to Veterans with PTSD
September 24, 2021
Ryan Allway September 24th, 2021 App, Exclusive, Psychedelics, Top Story Post-traumatic stress disorder, or PTSD, is a common mental illness among veterans. According to the Department of Veteran Affairs, 11% to 30% of veterans who served in foreign wars experience PTSD, far higher than the estimated 6% of the... Read more
BioHarvest Provides Unmatched Consistency & Variety in Cannabis
September 14, 2021
Ryan Allway September 14th, 2021 App, Exclusive, News, Top Story The cannabis industry is quickly evolving from dried cannabis to beverages and other product formats. At the same time, the pharmaceutical industry is increasingly embracing cannabinoids for their potential therapeutic benefits. The challenge is converting raw plant material into... Read more
Patented Data and Devices for Pharmaceutical Cannabis
September 9, 2021
Ryan Allway September 9th, 2021 News, Top Story For all of the talk about cannabis as a medicine and potential treatment for a wide variety of ailments, from sleep to stress to pain disorders and more, there is a huge missing element. There are almost no FDA-approved cannabis-derived medicines.... Read more
